AXDORZ-T
COMPOSITION:- Dorzolamide 2% w/v + Timolol 0.5% w/v Eye Drops IP
PACKAGE:- 5ml
Devaksh Lifesciences offers AXDORZ-T as a potent combination therapy for managing elevated intraocular pressure (IOP). This formula is aimed at reducing the cause of Ocular hypertension, making use of Dorzolamide to prevent the production of aqueous humour and Timol to reduce fluid production. Such a combination produces a synergistic effect which is much more effective than monotherapy and will guarantee the protection of the optic nerve.
Key Features:
- Synergistic dual-action formula in order to achieve peak IOP reduction.
- Very ideal in patients who are unresponsive to single-drug therapy.
- Helps to avoid progressive vision loss that is related to glaucoma.
- Targeted action with minimal systemic absorption
Benefits & Advantages:
- Reduces considerably the risk of permanent damage of the optic nerve.
- The need to have many bottles is minimized by convenient combination.
- Stable, 24-hour controlled pressure including twice-daily dosage.
- Clinically proven long-term chronic safety.
Usage & Clinical Highlights:
- First line therapy in Open-Angle Glaucoma and Ocular Hypertension.
- Intended to be used on patients who need aggressive pressure relief.
- Minimizes the effect of washout observed when two independent drops are used.
- Proven to be clinically superior in target IOP sustenance of 24 hours.
- Critical in the prevention of the development of visual field defects.
